“During early process development, every relevant
aspect of a product’s lifecycle and cost-of-goods should
be taken into consideration.”
On October 3, 2022, David McCall, Commissioning Editor, Cell & Gene Therapy Insights, spoke to Kelly Kemp (left) and Sebastian Rieck (right) about current challenges in cell therapy process development and manufacture. This viewpoint has been written based on that interview.
